Sign In
Buy CYDY
$0.276
-0.0143 (-4.93%)
At Close: Jun 03, 2026
Shareholder Alert: Robbins LLP Announces that CytoDyn Inc. (CYDY) is Being Sued for Misleading Shareholders
06:32pm, Monday, 12'th Apr 2021
SAN DIEGO & VANCOUVER, Wash.--(BUSINESS WIRE)---- $CYDY #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of CytoDyn Inc. (OTC: CYDY) filed a class action complaint agai
New York, New York--(Newsfile Corp. - April 12, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of C
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytoDyn Inc. - CYDY
09:46pm, Saturday, 10'th Apr 2021
New York, New York--(Newsfile Corp. - April 10, 2021) - Pomerantz LLP is investigating claims on behalf of investors of CytoDyn Inc. ("CytoDyn" or the "Company") (OTCQB: CYDY). Such investors are advi
RADNOR, Pa., April 10, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of CytoDyn Inc. (OTCMKTS: CYDY) ("CytoDyn") that a securities fraud class action lawsu
NEW YORK, April 9, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed against CytoDyn, Inc. ("CytoDyn" or the "C
New Orleans, Louisiana--(Newsfile Corp. - April 8, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have u
CytoDyn's COVID-19 Long-Hauler's Trial Closed as Enrollment Exceeds Goals
05:41pm, Thursday, 08'th Apr 2021
VANCOUVER, Washington, April 08, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 an
Why Auris Medical, CytoDyn and Prometheus Shares Are Moving Today
11:48am, Thursday, 08'th Apr 2021
Auris Medical Holding Ltd. (NASDAQ: EARS), CytoDyn Inc. (OTC: CYDY) and Prometheus Biosciences, Inc. (NASDAQ: RXDX) are among the biggest movers in the biopharma space Thursday.
CytoDyn set to deliver its leronlimab treatment to critically ill coronavirus (COVID-19) patients in the Philippines
04:49pm, Wednesday, 07'th Apr 2021
CytoDyn Inc (OTCQB:CYDY) announced it is delivering its drug leronlimab to a Philippine hospital to be administered to another 28 critically ill coronavirus (COVID-19) patients under a new Compassiona
CytoDyn Providing Leronlimab to a Philippine Hospital for 28 More COVID-19 Patients under Compassionate Special Permit (CSP)
04:01pm, Wednesday, 07'th Apr 2021
CytoDyn also negotiating the potential future delivery of 100,000 vials to the Philippines for additional CSP use
New York, New York--(Newsfile Corp. - April 7, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cy
CytoDyn inks exclusive supply and distribution agreement for leronlimab in Brazil with Biomm SA
07:51am, Wednesday, 07'th Apr 2021
CytoDyn Inc (OTCQB:CYDY), a biotechnology company developing its flagship drug Vyrologix (leronlimab-PRO 140) for multiple indications, said it has executed an exclusive supply and distribution agreem
New York, New York--(Newsfile Corp. - April 7, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytoDyn Inc. (OTCQB: CYDY) alleging that t
CytoDyn Signs Exclusive Supply and Distribution Agreement with Biomm S.A. in Brazil for COVID-19 and All Other Leronlimab Indications
06:00am, Wednesday, 07'th Apr 2021
VANCOUVER, Washington, April 07, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 an
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc.
07:38pm, Tuesday, 06'th Apr 2021
Radnor, Pennsylvania--(Newsfile Corp. - April 6, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn") investors that a securities fraud class actio
